Do You Know JAK? How Janus Kinase Inhibitors Have Been Game-Changers in the Treatment of Canine Atopic Dermatitis

There are a multitude of Janus kinase (JAK) inhibitor medications in human medicine, and with these types of medications currently playing the biggest role in the treatment of canine atopic dermatitis, more will be on the way in veterinary medicine. As this drug class increases, it is important to understand how they really work and what they can and cannot do. This webinar will explore the clinical uses of JAK inhibitors, review what safety regarding this drug class looks like, and discuss how to differentiate the available options.  

Not looking for CE credit for this course? You can skip entering your information below and proceed to viewing the webinar here.